Genome 发表于 2025-3-23 12:40:22

Submitted on: 23 December 2015.
Revised on: 14 March 2016.
Accepted on: 15 April 2016.

___________________ACTA PHARMACOLOGICA SINICA---NATURE PUBL GROUP

ICLE 发表于 2025-3-23 17:19:52

http://reply.papertrans.cn/1/5/439/439-12.png

放弃 发表于 2025-3-23 21:13:57

Submitted on: 09 December 2011.
Revised on: 09 March 2012.
Accepted on: 10 April 2012.

___________________ACTA PHARMACOLOGICA SINICA---NATURE PUBL GROUP

跳动 发表于 2025-3-24 02:09:07

http://reply.papertrans.cn/1/5/439/439-14.png

farewell 发表于 2025-3-24 04:20:25

Submitted on: 10 October 2004.
Revised on: 11 December 2004.
Accepted on: 03 February 2005.

___________________ACTA PHARMACOLOGICA SINICA---NATURE PUBL GROUP

osculate 发表于 2025-3-24 07:28:05

http://reply.papertrans.cn/1/5/439/439-16.png

AER 发表于 2025-3-24 12:27:03

Submitted on: 05 April 1998.
Revised on: 16 July 1998.
Accepted on: 26 July 1998.

___________________ACTA PHARMACOLOGICA SINICA---NATURE PUBL GROUP

AMEND 发表于 2025-3-24 17:25:26

http://reply.papertrans.cn/1/5/439/439-18.png

名字 发表于 2025-3-24 21:02:27

http://reply.papertrans.cn/1/5/439/439-19.png

训诫 发表于 2025-3-25 00:07:10

http://reply.papertrans.cn/1/5/439/439-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊ACTA PHARMACOLOGICA SINICA 2024/2025影响因子:6.987 (ACTA PHARMACOL SIN) (1671-4083). (PHARMACOLOGY & PHARMACY)(药理学与药学